Literature DB >> 12801844

Low platelet counts alone do not cause bleeding in an experimental immune thrombocytopenic purpura in mice.

Victoria Domínguez1, Tzipe Govezensky, Goar Gevorkian, Carlos Larralde.   

Abstract

BACKGROUND AND OBJECTIVES: The physiopathogenesis of hemorrhagic phenomena in patients with autoimmune thrombocytopenic purpura is associated with low platelet levels. In the present work the relation between thrombocytopenia and bleeding was examined. The possible participation of endothelial cells in bleeding was also investigated. DESIGN AND METHODS: Immune thrombocytopenia and bleeding were studied in mice injected with anti-mouse and anti-human platelet polyclonal rabbit IgG. Platelet levels were measured at different times and bleeding signs were systematically recorded. ANOVA tests were used to compare platelet levels. Binding of anti-platelet antibodies to vascular endothelial cells was analyzed by immunohistochemistry.
RESULTS: Three different doses of anti-platelet IgG caused the same low platelet levels, but bleeding occurred only with high doses of anti-platelet IgG irrespective of the platelet levels. No inflammation around blood vessels was observed in paraffin-embedded tissue sections of organs. Immunohistochemistry demonstrated anti-platelet antibodies bound to vascular endothelium. INTERPRETATION AND
CONCLUSIONS: We showed lack of correlation between platelet counts and bleeding in a murine model. The binding of anti-platelet IgG to endothelial cells of small vessels is an indication that antibody-mediated endothelial activation, in addition to thrombocytopenia, could be participating in bleeding.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12801844

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  9 in total

1.  Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury.

Authors:  Junichi Hirahashi; Keiichi Hishikawa; Shinya Kaname; Naotake Tsuboi; Yunmei Wang; Daniel I Simon; George Stavrakis; Tatsuo Shimosawa; Ling Xiao; Yutaka Nagahama; Kazuo Suzuki; Toshiro Fujita; Tanya N Mayadas
Journal:  Circulation       Date:  2009-09-14       Impact factor: 29.690

2.  ADAP is required for normal alphaIIbbeta3 activation by VWF/GP Ib-IX-V and other agonists.

Authors:  Ana Kasirer-Friede; Barry Moran; Jennifer Nagrampa-Orje; Ken Swanson; Zaverio M Ruggeri; Burkhart Schraven; Benjamin G Neel; Gary Koretzky; Sanford J Shattil
Journal:  Blood       Date:  2006-09-26       Impact factor: 22.113

3.  Characterization of Mice with a Platelet-Specific Deletion of the Adapter Molecule ADAP.

Authors:  Jochen Michael Rudolph; Karina Guttek; Gabriele Weitz; Clara Antonia Meinke; Stefanie Kliche; Dirk Reinhold; Burkhart Schraven; Annegret Reinhold
Journal:  Mol Cell Biol       Date:  2019-04-16       Impact factor: 4.272

4.  IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions.

Authors:  Mattias Collin; Oonagh Shannon; Lars Björck
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

5.  Platelet depletion in mice increases mortality after thermal injury.

Authors:  Satoshi Fujimi; Malcolm P MacConmara; Adrian A Maung; Yan Zang; John A Mannick; James A Lederer; Peter H Lapchak
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

6.  Inflammation induces hemorrhage in thrombocytopenia.

Authors:  Tobias Goerge; Benoit Ho-Tin-Noe; Carla Carbo; Charaf Benarafa; Eileen Remold-O'Donnell; Bing-Qiao Zhao; Stephen M Cifuni; Denisa D Wagner
Journal:  Blood       Date:  2008-02-06       Impact factor: 22.113

7.  A role for adhesion and degranulation-promoting adapter protein in collagen-induced platelet activation mediated via integrin α(2) β(1).

Authors:  G E Jarvis; D Bihan; S Hamaia; N Pugh; C J G Ghevaert; A C Pearce; C E Hughes; S P Watson; J Ware; C E Rudd; R W Farndale
Journal:  J Thromb Haemost       Date:  2012-02       Impact factor: 5.824

8.  Suppressive effects of anthrax lethal toxin on megakaryopoiesis.

Authors:  Po-Kong Chen; Hsin-Hou Chang; Guan-Ling Lin; Tsung-Pao Wang; Yi-Ling Lai; Ting-Kai Lin; Ming-Chun Hsieh; Jyh-Hwa Kau; Hsin-Hsien Huang; Hui-Ling Hsu; Chi-Yuan Liao; Der-Shan Sun
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

9.  IdeS: a bacterial proteolytic enzyme with therapeutic potential.

Authors:  Björn P Johansson; Oonagh Shannon; Lars Björck
Journal:  PLoS One       Date:  2008-02-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.